Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tyrosinase/gp100 Vaccine with/without IL-12 in Resected Melanoma
NCT00003339Phase 2Completed
- Sponsor
- University of Southern California
- Start
- Nov 1998
- Primary completion
- Nov 1999
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant interleukin-12 in melanoma, sponsored by University of Southern California. Started Nov 1998; status: completed.
02
Drugs
recombinant interleukin-12
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00003339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003339.